PharmaCyte Biotech Inc (PMCB)

[1234jklm]

Let’s stop the lies and dishonesty

This company is taking definite and successful steps to submitting its ind.

The tests required have been known for a long time. They’ve done what they said they’d do and it’s a remarkable achievement.

Of course shares in biotech get diluted while they’re in r&D.

Of course salaries have to be paid.

Does anyone else know of another biotech at 2 cents a share which is weeks from submitting an ind for an unmet medical need with a Principal Investigator who is based at Cornell and is one of the worlds leading pancreatic cancer oncologists?

Let’s stop the lies and fears.

This is a maverick company that is achieving something Herculean. Well done them.